{"id":"W2111508000","doi":"10.1016/s2213-2600(14)70165-1","title":"Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials","year":2014,"lang":"en","type":"article","venue":"The Lancet Respiratory Medicine","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":216,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Bayer Canada; University of Miami; Gilead Sciences","keywords":"Medicine; Bronchiectasis; Placebo; Cystic fibrosis; Sputum; Aztreonam; Internal medicine; Clinical endpoint; Chest physiotherapy; Randomized controlled trial; Physical therapy; Antibiotics; Tuberculosis; Lung","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008654556,0.0004118521,0.002469978,0.0004153941,0.0002158658,0.00002335548,0.000215269,0.000120793,0.0000659927],"category_scores_gemma":[0.006512056,0.000223134,0.0001397866,0.0004650861,0.0004430552,0.000204247,0.00005174616,0.0004003866,0.000007522918],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000184191,"about_ca_system_score_gemma":0.0001708173,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009414371,"about_ca_topic_score_gemma":0.0001385173,"domain_scores_codex":[0.9956889,0.0008925552,0.001234432,0.0005676224,0.0009294673,0.0006869986],"domain_scores_gemma":[0.9930152,0.005064344,0.000618302,0.0006672802,0.0003481516,0.0002867152],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.952406,0.0003273619,0.005611831,0.0004063761,0.0002480416,0.000003508069,0.0004397044,0.0001856353,0.01233957,0.0000597144,0.002514605,0.02545759],"study_design_scores_gemma":[0.962726,0.006612563,0.01770922,0.0009317024,0.0007013506,0.000004169981,0.00009141186,0.005471837,0.001306671,0.0001426576,0.004035667,0.0002667319],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9688256,0.0009797639,0.01308265,0.004791343,0.0002093421,0.01148334,0.00004298689,0.00008362439,0.0005013378],"genre_scores_gemma":[0.9943485,0.00003048299,0.00121227,0.0009703783,0.001596015,0.001561013,0.0001549986,0.00005562137,0.00007073842],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02552287,"threshold_uncertainty_score":0.9099142,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05655917201765907,"score_gpt":0.3748178336932471,"score_spread":0.318258661675588,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}